We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back to Event-Details

Key Initiatives in Europe to Walk the Talk in Patient-Focused Medicines Development - An interactive update and Discussion with Different Stakeholders

Track:
Hot Topic/Stand Alone

Day & Time:
April 19, 10:30AM - 12:00PM (Central Europe Standard Time)

Session Number:
S1005

Room Number:
Boston 1-2

Type:
Session

Title:
Key Initiatives in Europe to Walk the Talk in Patient-Focused Medicines Development - An interactive update and Discussion with Different Stakeholders

Chair(s):
Lode Dewulf, MD, FFPM
Chief Patient Officer
Servier, France

Description:
Health stakeholders agree on the importance of improving patient engagement (PE) across all phases of medicines development. What can we learn from the experience and perspectives of different stakeholders? How can we use these insights to address challenges and barriers and forge a more collaborative, connected PE ecosystem? What tools are available or in co-creation and how can we measure the impact of our PE efforts? Join us for a dynamic session that will explore these themes, and be an active participant by selecting priority topics to be addressed by PE leaders from diverse stakeholder groups.

Presentation(s) & Speaker(s):
Panel Discussion
Mathieu Boudes, PhD
PARADIGM Coordinator
European Patients' Forum, France

Panel Discussion
Neil Bertelsen, MBA, MSc
Chair, Patient and Citizen Involvement in HTA IG
Health Technology Assessment international (HTAi), Germany

Panel Discussion
Soren E Skovlund
Senior Reaearcher, lead, PRO
Aalborg University, Denmark

Panel Discussion
Nicholas Brooke, MBA
Executive Director
The Synergist / Pfmd.Org, Belgium